A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG
- PMID: 8162068
- DOI: 10.1038/ng0294-146
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG
Abstract
The t(11;22)(q24;q12), present in 85% of Ewing's sarcoma and related tumours, fuses the EWS gene from chromosome 22q12 and the ETS family member, FLI-1. This results in the expression of a chimaeric protein containing the amino-terminal portion of EWS fused to the ETS DNA-binding domain of FLI-1. We have identified a second Ewing's sarcoma translocation, t(21;22)(q22;q12), that fuses EWS to a different ETS family member, the ERG gene located on band 21q22. Identical EWS nucleotide sequences found in the EWS/FLI-1 fusion transcripts are fused to portions of ERG encoding an ETS DNA-binding domain resulting in expression of a hybrid EWS/ERG protein. These findings suggest that fusion of EWS to different members of the ETS family of transcription factor genes may result in the expression of similar disease phenotypes.
Similar articles
-
A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.Oncogene. 1995 Mar 16;10(6):1229-34. Oncogene. 1995. PMID: 7700648
-
A new member of the ETS family fused to EWS in Ewing tumors.Oncogene. 1997 Mar 13;14(10):1159-64. doi: 10.1038/sj.onc.1200933. Oncogene. 1997. PMID: 9121764
-
Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.Oncogene. 1995 Feb 2;10(3):423-31. Oncogene. 1995. PMID: 7845667
-
Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.Cancer Genet Cytogenet. 2008 Mar;181(2):81-92. doi: 10.1016/j.cancergencyto.2007.11.002. Cancer Genet Cytogenet. 2008. PMID: 18295659 Review.
-
The ETS oncogene family in development, proliferation and neoplasia.Int J Hematol. 1994 Jun;59(4):257-65. Int J Hematol. 1994. PMID: 8086619 Review.
Cited by
-
Current Status of Management and Outcome for Patients with Ewing Sarcoma.Cancers (Basel). 2021 Mar 10;13(6):1202. doi: 10.3390/cancers13061202. Cancers (Basel). 2021. PMID: 33801953 Free PMC article. Review.
-
Molecular cytogenetic characterization of two established ESFT cell lines.Hum Cell. 2017 Jan;30(1):41-48. doi: 10.1007/s13577-016-0145-7. Epub 2016 Sep 9. Hum Cell. 2017. PMID: 27613543
-
Ewing sarcoma and Ewing-like tumors.Virchows Arch. 2020 Jan;476(1):109-119. doi: 10.1007/s00428-019-02720-8. Epub 2019 Dec 4. Virchows Arch. 2020. PMID: 31802230 Review.
-
Extraskeletal Ewing sarcoma of the sciatic nerve.Radiol Case Rep. 2023 Jan 12;18(3):1221-1226. doi: 10.1016/j.radcr.2022.12.006. eCollection 2023 Mar. Radiol Case Rep. 2023. PMID: 36660563 Free PMC article.
-
TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma.Cancer Med. 2019 Dec;8(18):7809-7821. doi: 10.1002/cam4.2647. Epub 2019 Nov 6. Cancer Med. 2019. PMID: 31692287 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials